Pharmaceutical services and/or pharmaceutical care for elderly individuals with multimorbidity, polypharmacy, and hearing impairment: Scope review
DOI:
https://doi.org/10.33448/rsd-v14i4.48619Keywords:
Aging; Hearing Impairment; Polypharmacy; Pharmaceutical Care; Pharmaceutical Services.Abstract
Objective: To map the tools and strategies applied in pharmaceutical services and/or pharmaceutical care for elderly individuals with polymorbidities, polypharmacy, and hearing impairment in the context of health education. Methodology: This is a scoping review following the guidelines established by the JBI, guided by the acronym PCC in which: Participants: Elderly individuals with polymorbidities, polypharmacy, and hearing impairment; Concept: Educational Strategies and Tools; Context: Pharmaceutical Services and/or Pharmaceutical Care. The expected time frame was from 2020 to 2024, published in Portuguese, Spanish, and English. Scientific databases, repositories of scientific articles, and Google Scholar were used. Results: six articles met the inclusion criteria. The studies summarize the specificities of the demands of elderly patients with polymorbidities, polypharmacy, and hearing impairment, highlighting the measures and tools implemented in health services for this population, from the perspective of what is recommended and what is found in the practice of pharmaceutical services for effective communication with the patient. Conclusion: Elderly patients with hearing impairment who present a picture of polymorbidities and consequent polypharmacy have needs which Goes beyond purely pharmaceutical knowledge. They are required to understand cultural and linguistic aspects and demand specific pharmaceutical care strategies.
References
Aromataris, E., & Munn, Z. (Editors). (2020). JBI Manual for Evidence Synthesis. JBI. https://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-20-01. ISBN: 978-0-6488488-0-6
Blakely, M. L., & Salvo, M. C. (2019). Improving communication between healthcare professionals and deaf and hard of hearing patients. Research in social & administrative pharmacy: RSAP, 15(9), 1193–1194. https://doi.org/10.1016/j.sapharm.2019.03.076
Brasil. (2003). Congresso Nacional. Lei nº 10.741, de 1º de outubro de 2003. Dispõe sobre o estatuto do idoso e dá outras providências. Diário Oficial da União: seção 1, Brasília, DF, 3 out. https://www.planalto.gov.br/ccivil_03/leis/2003/L10.741.htm.
Brasil. (2020). Ministério da Ciência, Tecnologia e Inovações. Livro Verde: Ciência, Tecnologia e Inovação para o Desenvolvimento Nacional. Brasília, DF: MCTI. https://www.gov.br/mcti.
Brasil. (2021). Ministério da Saúde. Cadernos de Atenção Básica: Envelhecimento e Saúde da Pessoa Idosa. Brasília, DF: Ministério da Saúde. https://bvsms.saude.gov.br.
Brasil. (2012). Ministério da Saúde. Política Nacional de Educação Permanente em Saúde: o que se tem produzido para o seu fortalecimento? Brasília, DF: Ministério da Saúde. https://bvsms.saude.gov.br.
Centre For Evidence-Based Medicine. (2009). Nuffield Department of Primary Care Health Sciences. Radcliffe Primary Care Building. University of Oxford. Woodstock Road, Oxford.
Conselho Federal de Farmácia (CFF). (2020). Resolução nº. 596, de 21 de fevereiro de 2020. Dispõe sobre o Código de Ética Farmacêutica, o Código de Processo Ético e estabelece as infrações e as regras de aplicação das sanções disciplinares.
Cordeiro, L., & Baldini, S. C. (2020). Revisão de escopo: potencialidades para a síntese de metodologias utilizadas em pesquisa primária qualitativa. BIS Boletim do Instituto de Saúde, 20, 37–43. https://doi.org/10.52753/bis.2019.v20.34471.
Critical Appraisal Skills Programme (CASP). CASP checklist: 10 questions to help you make sense of qualitative research. Oxford. UK. 2018.
https://casp-uk.net/checklists/casp-qualitative-studies-checklist-fillable.pdf
Brito-Araújo, M., Gomes, N. P., & Marquez, C. O. (2023). Atenção farmacêutica para pessoas surdas: uma revisão bibliográfica. Research, Society and Development, 12(1), e2812139452-e2812139452. https://doi.org/10.33448/rsd-v12i1.39452
Oliveira, L. M. Z., & Pinto, R. R. (2021). A utilização da polifarmácia entre idosos e seus riscos/The use of polypharmacy among the elderly andtheir risks. Brazilian Journal of Development, 7(11), 104763-104770. https://doi.org/10.34117/bjdv7n11-209
Galvão, A., Siqueira, M. L., & Soler, O. (2024). Assistência farmacêutica e/ou cuidado farmacêutico aplicados ao usuário surdo: Revisão de escopo. Research, Society and Development, 13(1), p. e8013144813. DOI: 10.33448/rsd-v13i1.44813. https://rsdjournal.org/index.php/rsd/article/view/44813.
Ibrahim, A. S. H., Barry, H. E.; Hughes, C. M. (2021). A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy. Family Practice, 38(4), 509-523. DOI: 10.1093/fampra/cmaa146. https://doi.org/10.1093/fampra/cmaa146
Kardas, P., Mair, A., Stewart, D., & Lewek, P. (2023). Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application. Frontiers in Pharmacology, 14. 1254912. DOI 10.3389/fphar.2023.1254912. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1254912/full
Laberge, M., Sirois, C., Lunghi, C., et al. (2021). Economic evaluations of interventions to optimize medication use in older adults with polypharmacy and multimorbidity: a systematic review. Clinical Interventions in Aging, 16, 767-779. DOI: 10.2147/CIA.S304074.
Murad, M. H., Asi, N., Alsawas, M., & Alahdab, F. (2016). New evidence pyramid. Evid Based Med, 21(4), 125-127.https://ebm.bmj.com/content/ebmed/21/4/125.full.pdf
O’Neill, J., Tabish, H., Welch, V., et al. (2014). Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J Clin Epidemiol, 67, 56-64. DOI: 10.1016/j.jclinepi.2013.08.005
OpenAI. ChatGPT (Modelo GPT-4). (2025). Serviços farmacêuticos e/ou cuidado farmacêutico para idosos com polimorbidades, polifarmácia e deficiência auditiva. https://chatgpt.com/share/67e54f9a-cf2c-8000-96f0-ae4f6abf2b2a.
Soler, O.; & Barreto, J. O. M. (2019). Community-Level Pharmaceutical Interventions to Reduce the Risks of Polypharmacy in the Elderly: Overview of Systematic Reviews and Economic Evaluations. Frontiers in Pharmacology, 10, 302, 2019. DOI: 10.3389/fphar.2019.00302.
Page, M. J., Mckenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.), 372(71). https://doi.org/10.1136/bmj.n71
Paula, K. C., Francisco, G. S. A. M. ., Sá, T. M., & Miranda, E. S. (2022). Experiences of pharmaceutical care practices for deaf people: an integrative literature review. Research, Society and Development, 11(1), e12411124604. https://doi.org/10.33448/rsd-v11i1.24604
Pereira, M. H. S., Alves, G. C., & Soler, O. (2024). Serviços farmacêuticos e/ou cuidado farmacêutico para idosos com polimorbidades, polifarmácia e deficiência auditiva: revisão de escopo. DOI: https://doi.org/10.17605/OSF.IO/BDQVR. https://osf.io/bdqvr/
Peters, M. D., Godfrey, C., McInerney, P., Munn, Z., Tricco, A. C., & Khalil, H. (2024). Scoping reviews. JBI Manual for Evidence Synthesis. JBI. https://doi.org/10.46658/JBIMES-24-09.
Quadros R. M., & Kanopp L. B. (2004). Língua de Sinais Brasileira. Estudos linguísticos. Editora Artmed.
Quadros, R. M. (2004). O tradutor e intérprete de língua brasileira de sinais e língua portuguesa. SEESP. Karnopp, E. Q.; Quadros, R. M. 2004. Língua de sinais brasileira – estudos linguísticos. . Editora Artmed.
Rezende, R. F., Guerra, L. B., & Carvalho, S. A. S. (2021). A perspectiva do paciente surdo acerca do atendimento à saúde. Revista Cefac, 23, e0620. https://doi.org/10.1590/1982-0216/20212320620
Saunders, G. H., Thomas, S., Griffiths, J., Nurs, R. G. N., et al. (2023). Hearing Loss at the Pharmacy: A Qualitative Study of Pharmacists and Their Clients. The Hearing Journal, 76(05), 26,27,28, DOI: 10.1097/01.HJ.0000935968.26392.01
Souza, J. P., Marinho, J. L., & Mendonça, R. T. (2024). Acessibilidade ao cuidado farmacêutico por pessoas com deficiência auditiva. Revista Foco. 17(10), e6275, p. 1-17. DOI: 10.54751/revistafoco.v17n10-146
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Editora UAB/NTE/UFSM.
Pereira, K. G., Peres, M. A., Iop, D., Boing, A. C., Boing, A. F., Aziz, M., & d’Orsi, E. (2017). Polifarmácia em idosos: um estudo de base populacional. Revista Brasileira de Epidemiologia, 20(2), 335–344. https://doi.org/10.1590/1980-5497201700020013
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., et al. (2018). PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explicação. Ann Intern Med.,169, 467-473. Doi: 10.7326/M18-0850
Vasconcelos, S. dos S. ., Novais, G. S. ., Weekes, K. W. ., Silva, M. C. P. da ., Costa, G. de L. C. ., & Vallinoto, I. M. V. C. . (2021). Brazilian Sign Language in health: Evaluation from the perspective of patients and medical students. Research, Society and Development, 10(8), e15510816225. https://doi.org/10.33448/rsd-v10i8.16225
Vieira, G. G., Tolentino, N. S., Melo, M. V., & Nunes, M. R. (2024). A prática da polifarmácia na Atenção Primária à Saúde. Research, Society and Development, 13(10), e38131047006. DOI: http://dx.doi.org/10.33448/rsd-v13i10.47006.
Weerapol, N., & Leelakanok, N. (2024). Communication between healthcare professionals and patients with hearing loss: a systematic review and meta-analysis. American Journal of Health-System Pharmacy, 81(12), 521-530. DOI: 10.1093/ajhp/zxae045. https://doi.org/10.1093/ajhp/zxae045
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Gregório Carvalho Alves; Marcelo Henrique Silva Pereira; Orenzio Soler
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
